Tag: congestive heart failure treatment devices market insights

  • Congestive Heart Failure Treatment Devices Market Key Insights 2024-2033: Growth Rate, Trends And Opportunities

    Congestive Heart Failure Treatment Devices Market Key Insights 2024-2033: Growth Rate, Trends And Opportunities

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Congestive Heart Failure Treatment Devices Market from 2024 to 2033?
    The congestive heart failure treatment devices market has shown strong growth. It is projected to increase from $18.22 billion in 2023 to $19.61 billion in 2024, at a CAGR of 7.6%. This growth is influenced by the shift towards less invasive surgical options, demand for minimally invasive devices, and increased healthcare expenditure.

    The congestive heart failure treatment devices market is expected to see strong growth, reaching $26.57 billion by 2028 with a CAGR of 7.9%. Growth factors include an aging population and favorable reimbursement policies. Key trends include the adoption of transcatheter valve replacement and remote monitoring solutions.

    Claim Your Free Sample of the Global Congestive Heart Failure Treatment Devices Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15774&type=smp

    What Key Factors Are Fueling the Growth of the Congestive Heart Failure Treatment Devices Market?
    The rise in the prevalence of cardiovascular disorders is expected to propel the growth of the congestive heart failure treatment devices market going forward. Cardiovascular disorders encompass a range of diseases affecting the heart and blood vessels, including coronary artery disease, hypertension, and heart failure, impacting blood circulation and overall heart health. The rise in the prevalence of cardiovascular disorders is primarily due to increasing rates of risk factors such as obesity, sedentary lifestyles, poor diets, and aging populations. Congestive heart failure treatment devices are crucial in managing cardiovascular disorders by regulating heart rhythms and improving heart function, significantly enhancing patient outcomes. For instance, in March 2022, according to the Office for National Statistics, a UK-based national statistical authority, the number of deaths due to heart attacks was 20,061 in 2021, increasing from 19,440 in 2020. Therefore, the rise in the prevalence of cardiovascular disorders is driving the growth of the congestive heart failure (CHF) treatment devices market.

    What Are the Major Segments of the Congestive Heart Failure Treatment Devices Market?
    1) By Product: Cardiac Pacemaker, Implantable Cardioverter Defibrillators (ICDs), Cardiac Resynchronization Therapy Devices (CRT), Counter Pulsation Devices, Ventricular Assist Devices (VADs)
    2) By Application: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)
    3) By End-User: Hospitals And Clinic, Specialized Cardiovascular Disease Treatment Centers, Ambulatory Surgery Centers

    What New Trends Are Transforming the Congestive Heart Failure Treatment Devices Market?
    Major players in the congestive heart failure treatment devices market are innovating pacemakers with Bluetooth connectivity. In June 2021, Microport Crm S.R.L. launched Alizea and Borea pacemakers, enabling remote monitoring by cardiologists and reducing the need for hospital visits.

    Order Now for Fast Delivery of Your Congestive Heart Failure Treatment Devices Market Report!
    https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-treatment-devices-global-market-report

    Which Regions Are Driving Growth in the Congestive Heart Failure Treatment Devices Market?
    North America was the largest region in the congestive heart failure treatment devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congestive heart failure treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    The Congestive Heart Failure Treatment Devices Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the congestive heart failure treatment devices market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Congestive Heart Failure Treatment Devices Market Include

    1. Congestive Heart Failure Treatment Devices Market Executive Summary
    2. Congestive Heart Failure Treatment Devices Market Segments
    3. Congestive Heart Failure Treatment Devices Market Size And Template Market Growth Rate
    4.  Key Congestive Heart Failure Treatment Devices Market Trends
    5. Major Congestive Heart Failure Treatment Devices Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Congestive Heart Failure Treatment Devices Market
    26. Top Congestive Heart Failure Treatment Devices Companies
    27. Congestive Heart Failure Treatment Devices Market Opportunities And Strategies
    28. Congestive Heart Failure Treatment Devices Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

    Urinary Stone Treatment Devices And Equipment Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/urinary-stone-treatment-devices-and-equipment-global-market-report

    Gastrointestinal Bleeding Treatment Devices Size Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Congestive Heart Failure Treatment Devices Market Analysis 2024: Size, Share, And Key Trends

    Global Congestive Heart Failure Treatment Devices Market Analysis 2024: Size, Share, And Key Trends

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Current Market Dynamics

    • Market Size: The congestive heart failure treatment devices market grew from $18.22 billion in 2023 to $19.61 billion in 2024.
    • Growth Rate: This represents a compound annual growth rate (CAGR) of 7.6%.
    • Historical Drivers:
      • Shift towards less invasive surgical techniques.
      • Demand for minimally invasive structural heart devices.
      • Ongoing training and education programs for healthcare professionals.
      • Rising healthcare expenditure.
      • Growing patient preference for non-surgical or minimally invasive treatment options.

    Read More On The Congestive Heart Failure Treatment Devices Market Report 2024 –
    https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-treatment-devices-global-market-report

    Future Market Projections

    • Projected Growth: The market is expected to grow to $26.57 billion by 2028.
    • Forecast CAGR: Reflects a CAGR of 7.9%.
    • Future Drivers:
      • Increasing aging population.
      • Growing awareness about heart health.
      • Implementation of screening programs.
      • Favorable reimbursement policies for structural heart procedures.
      • Timely regulatory approvals for new structural heart devices.

    Impact of Cardiovascular Disorders

    • Market Growth: The increasing prevalence of cardiovascular disorders is driving the expansion of the congestive heart failure treatment devices market.
    • Cardiovascular Disorders:
      • Include coronary artery disease, hypertension, and heart failure.
      • Driven by factors such as obesity, sedentary lifestyles, poor diets, and aging populations.
    • Role of CHF Devices: These devices are crucial in managing cardiovascular disorders by regulating heart rhythms and improving heart function, significantly enhancing patient outcomes.
    • Example: In the UK, deaths due to heart attacks increased from 19,440 in 2020 to 20,061 in 2021, highlighting the growing need for effective CHF treatment devices.

    Technological Innovation in CHF Treatment Devices

    • Bluetooth-Enabled Pacemakers: Companies are developing pacemakers with Bluetooth connectivity to enhance remote monitoring and patient care.
      • Example: Microport Crm S.R.L. launched Alizea and Borea pacemakers in June 2021, featuring Bluetooth technology for remote monitoring, reducing the need for hospital visits, and supporting continuous patient follow-up.
      • Benefits: These pacemakers, with a projected lifespan of 13 years, include advanced features like safer mode and real-time electrogram (EGM), improving healthcare management.

    Strategic Acquisitions in the Market

    • Johnson & Johnson’s Acquisition of Abiomed Inc.: In December 2022, Johnson & Johnson acquired Abiomed Inc. for $16.6 billion.
      • Purpose: To expand its MedTech business into the cardiovascular device market, particularly in heart failure and recovery solutions.
      • Abiomed Inc.: A US-based manufacturer of congestive heart failure treatment devices.

    Market Segmentation

    • By Product:
      • Cardiac Pacemaker
      • Implantable Cardioverter Defibrillators (ICDs)
      • Cardiac Resynchronization Therapy Devices (CRT)
      • Counter Pulsation Devices
      • Ventricular Assist Devices (VADs)
    • By Application:
      • Left Ventricular Assist Device (LVAD)
      • Right Ventricular Assist Device (RVAD)
      • Biventricular Assist Device (BIVAD)
    • By End-User:
      • Hospitals and Clinics
      • Specialized Cardiovascular Disease Treatment Centers
      • Ambulatory Surgery Centers

    Regional Insights

    • North America: The largest region in the congestive heart failure treatment devices market in 2023.
    • Asia-Pacific: Expected to be the fastest-growing region during the forecast period.

    The congestive heart failure treatment devices market is set for continued growth, driven by increasing cardiovascular disorders, technological advancements, and strategic acquisitions. The market’s expansion is supported by a growing demand for minimally invasive solutions and the aging global population, positioning it for significant growth in the coming years.

    Request for A Sample Of The Global Congestive Heart Failure Treatment Devices Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=15774&type=smp